# US 2021/0338988 A1 · Vascular closure device and related methods

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0338988 A1
- Document ID: US20210338988A1
- Status: Published application
- Kind: A1
- Application number: 16/864,865
- Filed: 2020-05-01
- Published: 2021-11-04
- Earliest claimed: 2020-05-01
- Assignees: Terumo Medical Corporation
- Applicants: Terumo Medical Corporation
- Inventors: Junya KOJIMA
- Web page: https://patentgrep.com/patent/US20210338988A1

## CPC

- A61M 25/10: Balloon catheters ({A61M25/0125 takes precedence; embolectomy A61B17/22032; retractors A61B17/02;} inflatable balloons for placing stents or stent-grafts A61F2/958 {; stomach balloons for treatment of obesity A61F5/0003; oesophagal tubes A61J15/00})
- A61B 17/0057: {Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect (sutures A61B17/04; closing rectum or urethra near body surface A61F2/0009)}
- A61M 39/0247: {Transcutaneous or percutaneous access sites to the inside of the body}
- A61P 7/04: Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A61B 2017/0061: {Implements located only on one side of the opening}
- A61B 2017/0065: {the implement being an adhesive}
- A61B 2017/00659: {located only on one side of the opening}
- A61B 2017/00672: {Locating means therefor, e.g. bleed back lumen}
- A61M 25/1002: {characterised by balloon shape (A61M25/1006, A61M25/1009 take precedence)}
- A61M 2025/1052: {for temporarily occluding a vessel for isolating a sector}
- A61M 2039/0258: {for vascular access, e.g. blood stream access}
- A61M 2202/0425: Thrombin
- A61M 2205/15: Detection of leaks
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present application discloses devices and methods for performing a vascular closure procedure that comprises inserting a sheath into a tissue tract defined in a body part, temporarily sealing a vascular access site, flushing the tissue tract with a flushing fluid via the sheath, dispensing a procoagulant material into the tissue tract adjacent the vascular access site via the sheath, and then unsealing the vascular access site to cause coagulation of blood adjacent the vascular access site.

## Claims

### Claim 1

A method of performing a vascular closure procedure at a vascular access site that has been formed through a wall of a blood vessel in a body part of a patient, the method comprising:
inserting a sheath into a tissue tract defined in the body part, the tissue tract being in fluid flow communication with an interior of the blood vessel via the vascular access site such that blood from the blood vessel may enter the tissue tract;
temporarily sealing the vascular access site so that blood from the blood vessel may no longer enter the tissue tract;
flushing the tissue tract with a flushing fluid via the sheath such that the tissue tract is substantially cleared of blood;
injecting a procoagulant material into the tissue tract via the sheath at a location adjacent the vascular access site; and
unsealing the vascular access site so that blood from the blood vessel interacts with the procoagulant material at the location.

### Claim 2 (depends on 1)

The method of claim 1, wherein the step of inserting the sheath into the tissue tract further comprises inserting the sheath into the tissue tract to abut an end of the sheath against the wall of the blood vessel, and wherein the steps of flushing the tissue tract and injecting a procoagulant material occur while the sheath is in this position.

### Claim 3 (depends on 1)

The method of claim 1, wherein the step of inserting the sheath into the tissue tract further comprises inserting the sheath into the tissue tract to abut an end of the sheath against the wall of the blood vessel, the method further comprising retracting the sheath to position the end in the tissue tract spaced apart from the wall of the blood vessel, prior to the step of injecting a procoagulant material.

### Claim 4 (depends on 1)

The method of claim 1, further comprising inserting a positioning catheter into the blood vessel via the sheath, the positioning catheter comprising a balloon or anchor, the balloon and anchor each having a first configuration capable of performing the step of temporarily sealing the vascular access site and a second configuration capable of performing the step of unsealing the vascular access site.

### Claim 5 (depends on 4)

The method of claim 4, wherein the step of temporarily sealing the vascular access site further comprises inflating a balloon of the positioning catheter inside the interior of the blood vessel and placing the positioning catheter under tension so that the inflated balloon presses against an interior surface of the wall of the blood vessel while covering the vascular access site.

### Claim 6 (depends on 5)

The method of claim 5, further comprising deflating the balloon of the positioning catheter while inside the interior of the blood vessel.

### Claim 7 (depends on 6)

The method of claim 6, wherein the at least a portion of the procoagulant material that is delivered to the location adjacent the vascular access site acts to coagulate blood located in the tissue tract into a plug, the method further comprising pulling the deflated balloon through the plug.

### Claim 8 (depends on 7)

The method of claim 7, further comprising injecting additional procoagulant material into the tissue tract via the sheath after the step of pulling the balloon through the plug.

### Claim 9 (depends on 6)

The method of claim 6, further comprising removing the balloon from the sheath immediately after the step of deflating the balloon.

### Claim 10 (depends on 1)

The method of claim 1, wherein the step of inserting the sheath into the tissue tract further includes placing one or more openings that are located adjacent an end of the sheath adjacent to the vascular access site prior to the step of flushing the tissue tract, wherein the step of flushing the tissue tract further comprises running the flushing fluid through the sheath and out of the one or more openings to substantially clear the tissue tract of blood.

### Claim 11 (depends on 1)

The method of claim 1, wherein the step of injecting a procoagulant material occurs from a plurality of different locations located on the sheath.

### Claim 12 (depends on 11)

The method of claim 11, wherein the step of injecting a procoagulant material occurs from the plurality of different locations simultaneously.

### Claim 13 (depends on 11)

The method of claim 11, wherein the step of injecting a procoagulant material occurs from the plurality of different locations at different times.

### Claim 14 (depends on 1)

The method of claim 1, wherein the step of injecting a procoagulant material further comprises injecting the procoagulant material into the tissue tract via a secondary nozzle that has been introduced through the sheath.

### Claim 15 (depends on 14)

The method of claim 14, further comprising locating a distal end of the secondary nozzle beyond a distal end of the sheath prior to or during the step of injecting a procoagulant material.

### Claim 16 (depends on 14)

The method of claim 14, wherein the step of injecting a procoagulant material further comprises moving the secondary nozzle away from the vascular access site while the step of injecting a procoagulant material is occurring.

### Claim 17 (depends on 14)

The method of claim 14, wherein the step of injecting a procoagulant material further comprises moving the secondary nozzle towards the vascular access site while the step of injecting a procoagulant material is occurring.

### Claim 18 (depends on 1)

The method of claim 1, further comprising, after the step of injecting a procoagulant material, monitoring for blood leakage and performing a second injecting step in which a procoagulant material is introduced into the tissue tract if blood leakage is detected.

### Claim 19 (depends on 1)

The method of claim 1, wherein the step of injecting a procoagulant material comprises injecting a procoagulant material and a solvent material at the location.

### Claim 20 (depends on 19)

The method of claim 19, wherein the step of injecting a procoagulant material comprises injecting the procoagulant material and the solvent material at the location simultaneously.

### Claim 21 (depends on 19)

The method of claim 19, wherein the step of injecting a procoagulant material comprises injecting the procoagulant material and the solvent material at the location at different times.

### Claim 22 (depends on 19)

The method of claim 19, wherein the step of injecting a procoagulant material comprises injecting the procoagulant material and the solvent material at the location at alternating times.

### Claim 23 (depends on 1)

The method of claim 1, wherein the step of injecting a procoagulant material comprises injecting a procoagulant material and a solvent material at the location, wherein the procoagulant material is comprised of cyanoacrylate and the solvent material is comprised of dimethyl sulfoxide.

### Claim 24

A vascular closure device comprising:
a sheath having a wall, the wall defining a cavity, the cavity including a plurality of flush openings located in the wall adjacent a first end of the cavity and a port located at a second end of the cavity, the port and the plurality of flush openings being in fluid flow communication, the sheath being adapted to be inserted within a tissue tract defined in a body part of a patient to a position adjacent a vascular access site formed through a wall of a blood vessel in the body part, the tissue tract being in fluid flow communication with an interior of the blood vessel via the vascular access site such that blood from the blood vessel may enter the tissue tract;
wherein, when the sheath is inserted within the tissue tract, a flushing fluid may be introduced into the cavity through the port such that the flushing fluid exits the cavity through the plurality of flush openings such that the sheath and the tissue tract are substantially cleared of blood.

### Claim 25 (depends on 24)

The vascular closure device of claim 24, wherein the plurality of flush openings are circumferentially arranged about the wall of the sheath adjacent the first end of the cavity thereof.

### Claim 26 (depends on 24)

The vascular closure device of claim 24, further comprising a nozzle attached to the sheath, wherein a first end of the nozzle is located interior to the cavity and a second end of the nozzle is located exterior to the cavity, the nozzle being adapted to allow for introduction of a second fluid into the cavity.

### Claim 27 (depends on 26)

The vascular closure device of claim 26, wherein the nozzle is adjustable to allow for relocation of the first end thereof to different positions within the cavity.

### Claim 28 (depends on 24)

The vascular closure device of claim 24, further comprising a blood flow indicator connected to the sheath.

### Claim 29

A method of performing a vascular closure procedure at a vascular access site that has been formed through a wall of a blood vessel in a body part of a patient, the method comprising:
inserting a sheath into a tissue tract defined in the body part, the tissue tract being in fluid flow communication with an interior of the blood vessel via the vascular access site such that blood from the blood vessel may enter the tissue tract;
inserting a positioning catheter through the sheath into the blood vessel, the positioning catheter comprising a cavity and a nozzle slidably attached thereto such that a position of a distal end of the nozzle is adjustable with respect to a distal end of the cavity;
temporarily sealing the vascular access site so that blood from the blood vessel may no longer enter the tissue tract;
flushing the tissue tract with a flushing fluid via the sheath or the nozzle such that the tissue tract is substantially cleared of blood;
injecting a procoagulant material into the tissue tract via the nozzle at a location adjacent the vascular access site; and
unsealing the vascular access site so that blood from the blood vessel interacts with the procoagulant material at the location.
